How to Buy Intuitive Surgical Stock
Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Intuitive Surgical stock last closed at $476.32, down 0.45% from the previous day, and has decreased 19.39% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.03 percentage points. Intuitive Surgical stock is currently +12.08% from its 52-week low of $425.00, and -21.8% from its 52-week high of $609.08.
As of Feb 5, 2026, there are 355.13M ISRG shares outstanding. The market cap of ISRG is $169.16B. In the last 24 hours, 2.91M ISRG shares were traded.
How to Buy Intuitive Surgical Stock
Not sure how to invest in Intuitive Surgical stock? Here's how.
- Decide where to buy Intuitive Surgical stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you determine where to buy Intuitive Surgical stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Choose your payment method and add your information.
- Research Intuitive Surgical stock: The Intuitive Surgical ticker symbol is ISRG. Is Intuitive Surgical stock a good investment? Should you buy shares of ISRG? How do ISRG's underlying business fundamentals look? Do top analysts think Intuitive Surgical is a good buy? Why has ISRG's stock price moved recently? (Hint: Our stock market research tools can help you understand if ISRG is a good stock to buy).
- Execute your ISRG buy order: Decide if you will purchase ISRG shares at the current market price or use a limit order to buy ISRG stock at a specific price.
- Track your ISRG position: Create a watchlist to watch your investment in Intuitive Surgical stock.
Step 1: Decide where to buy Intuitive Surgical stock
You will need an online brokerage account in order to access the NASDAQ market and buy ISRG shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal information so you can invest in ISRG today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open a new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on the best stock app for beginners, you need to deposit funds:
Check out the video below to see the process of depositing funds into your brokerage account.
Step 4: Research Intuitive Surgical stock
After you have identified the best place to buy Intuitive Surgical stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and opportunity.
Overview of key ISRG info
Fundamentals of Intuitive Surgical
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ISRG's stock page.
Is ISRG stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge ISRG's intrinsic value.
Using relative valuations ratios:
- ISRG may be undervalued based on its P/E ratio of 59.54x, relative to Medical Instruments & Supplies industry P/E ratio of 181.83x
- ISRG could be overvalued based on its P/B ratio of 9.49x, relative to Medical Instruments & Supplies industry P/B ratio of 3.03x
- ISRG may be overvalued based on its PEG ratio of 3.19x
You can access additional valuation analysis on ISRG's stock here.
A quick look at ISRG Financials
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the ISRG balance sheet.
- There are more short-term assets than long-term liabilities on the ISRG balance sheet.
- Total ISRG debt is lower than 5 years ago, relative to shareholder equity.
- ISRG has a low debt to equity ratio of 0.14.
- ISRG's operating cash flow of $3.03B allows it to safely service it's debt of $0.00.
- ISRG profit margin has gone up from 27.8% to 28.4% in the past year.
- ISRG earnings of $3.29B is not enough to cover its interest payments.
Do Wall Street analysts think it's a good time to buy Intuitive Surgical stock
Out of 12 Wall Street analysts who give recommendations on ISRG, the consensus analyst rating on Intuitive Surgical is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent ISRG Analyst Upgrades/Downgrades
Adam Maeder, a top 22% analyst from Piper Sandler maintains ISRG with a strong buy rating and raises their ISRG price target from $610.00 to $620.00, on Jan 23, 2026.
Piper Sandler's Adam Maeder raised their price target on Intuitive Surgical (NASDAQ: ISRG) by 1.6% from $610 to $620 on 2026/01/23. The analyst maintained their Strong Buy rating on the stock.
Intuitive Surgical reported its Q4 and FY 2025 earnings.
Raising their price target in response, Maeder noted the quarter beat both revenue and EPS consensus estimates and management conffirmed the FY 2026 procedure guidance it released earlier this month.
Earnings Report
Intuitive Surgical reported:
For Q4 2025:
- EPS of $2.53, which beat the Zacks Consensus Estimate of $2.25 and Q4 2024's $2.40.
- Revenue of $2.87B, which beat the Zacks Consensus Estimate by 4.7% and was up 19.1% Y/Y.
For FY 2025:
- EPS of $8.93, up from FY 2024's $7.34.
- Revenue of $10.07B, up from FY 2024s' $8.35.
Management did not provide revenue and earnings guidance or commentary in its press release.
Lee Hambright, a top 30% analyst from Bernstein maintains ISRG with a buy rating and raises their ISRG price target from $740.00 to $750.00, on Jan 23, 2026.
Ryan Zimmerman, a top 13% analyst from BTIG reiterates ISRG with a strong buy rating and maintains their ISRG price target from $616.00 to $616.00, on Jan 23, 2026.
Richard Newitter, a top 13% analyst from Truist Securities maintains ISRG with a strong buy rating and raises their ISRG price target from $620.00 to $650.00, on Dec 18, 2025.
Shagun Singh, a top 27% analyst from RBC Capital maintains ISRG with a buy rating and raises their ISRG price target from $625.00 to $650.00, on Dec 17, 2025.
You can dig deeper into what analysts are forecasting on the Intuitive Surgical stock forecast page.
ISRG Technical Indicators
ISRG Growth Metrics
Last year, ISRG earnings were $2.86B. During the past five year, ISRG's earnings have grown by 21.51% per year. This was faster than the Medical Instruments & Supplies industry average of 14.39%.
Last year, ISRG revenue was $10.06B. In the last 5 year, ISRG's revenue has gone up by 18.22% per year. This was faster than the Medical Instruments & Supplies industry average of 12.54%.
Learn more about ISRG's earnings and revenue performance here.
What are ISRG insiders up to?
In the last 12 months, insiders at ISRG have sold more shares than they have bought.
Myriam Curet, EVP Chief Medical Officer of ISRG, was the latest ISRG insider to buy. They bought $26,321.40 worth of ISRG stock on Jan 29, 2026.
Get more info about who owns ISRG stock here.
Does ISRG stock generate passive income?
No, Intuitive Surgical doesn't provide an income stream by paying out dividends.
What others are saying about ISRG
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your ISRG buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, place a limit order.
Press the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Step 6: Track your ISRG position
Now that you own some ISRG shares, you'll want to keep up with your new company.
Start a watchlist to track your ISRG stock.
ISRG Feed
How to Buy Stock in Intuitive Surgical
To reiterate, here are the 6 steps to buy stock in Intuitive Surgical:
- Decide where to buy Intuitive Surgical stock
- Create your brokerage account
- Deposit money your investment account
- Research Intuitive Surgical stock
- Execute your ISRG buy order
- Track your ISRG position
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Intuitive Surgical, hit the button below to create your watchlist.
Other Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.